Relation of bone mineral density with clinical and laboratory parameters in pre-pubertal children with cystic fibrosis. 2009

Nazan Cobanoglu, and Halil Atasoy, and Ugur Ozcelik, and Ebru Yalcin, and Deniz Dogru, and Nural Kiper, and Ayhan Gocmen
Hacettepe University, Paediatric Pulmonary Diseases Unit, Ankara, Turkey. nazanc@hacettepe.edu.tr

To study bone mineral density (BMD) of pre-pubertal cystic fibrosis (CF) children, and its relation with clinical and laboratory parameters, we enrolled 16 CF (8 girls) (4-8 years), and 16 control children (8 girls) (4-8 years). After anthropometric measurements, BMD, serum calcium, phosphorus, total alkaline phosphatase (ALP), 25-hydroxy vitamin D (25-OHD), parathyroid hormone, osteocalcin, tumor necrosis factor (TNF)-alpha, soluble TNF-alpha receptor 2 (sTNFR2), and soluble IL-2 receptor (sIL-2R) levels, and urinary calcium and hydroxyproline excretions were assessed. Disease severity of CF patients was determined with Shwachman-Kulczycki clinical and Brasfield radiological scoring systems.The mean Shwachman-Kulczycki and Brasfield scores of CF patients were indicating well-controlled disease. The anthropometric measurements, mean BMD values, and serum calcium, phosphorus and parathyroid hormone levels were within normal range and similar in both groups. Serum osteocalcin levels were lower, and ALP and 25-OHD levels were higher in CF. Although 24-hr urinary calcium excretions was higher in CF patients, hydroxyproline excretions were similar in both groups. There was no difference between two groups for the serum levels of sIL-2R, TNF-alpha and sTNFR2. Children with low vertebral z-scores had higher serum sIL-2R levels in both groups, but the same relation could not be shown for TNF-alpha and sTNFR2.We may speculate that younger, healthier and well-nourished patients with CF may have normal BMD, but the bone disease develop as patients get older because of the other contributing factors. Future well-designed longitudinal studies with large cohorts might show a relation with BMD and cytokines in CF.

UI MeSH Term Description Entries
D008297 Male Males
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D002112 Calcifediol The major circulating metabolite of VITAMIN D3. It is produced in the LIVER and is the best indicator of the body's vitamin D stores. It is effective in the treatment of RICKETS and OSTEOMALACIA, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties. 25-Hydroxycholecalciferol,25-Hydroxyvitamin D 3,25-Hydroxycholecalciferol Monohydrate,25-Hydroxyvitamin D3,Calcidiol,Calcifediol Anhydrous,Calcifediol, (3 alpha,5Z,7E)-Isomer,Calcifediol, (3 beta,5E,7E)-Isomer,Calderol,Dedrogyl,Hidroferol,25 Hydroxycholecalciferol,25 Hydroxycholecalciferol Monohydrate,25 Hydroxyvitamin D 3,25 Hydroxyvitamin D3,Anhydrous, Calcifediol,Monohydrate, 25-Hydroxycholecalciferol
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000469 Alkaline Phosphatase An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.

Related Publications

Nazan Cobanoglu, and Halil Atasoy, and Ugur Ozcelik, and Ebru Yalcin, and Deniz Dogru, and Nural Kiper, and Ayhan Gocmen
January 1998, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine,
Nazan Cobanoglu, and Halil Atasoy, and Ugur Ozcelik, and Ebru Yalcin, and Deniz Dogru, and Nural Kiper, and Ayhan Gocmen
July 2005, Journal of paediatrics and child health,
Nazan Cobanoglu, and Halil Atasoy, and Ugur Ozcelik, and Ebru Yalcin, and Deniz Dogru, and Nural Kiper, and Ayhan Gocmen
January 2008, Respiration; international review of thoracic diseases,
Nazan Cobanoglu, and Halil Atasoy, and Ugur Ozcelik, and Ebru Yalcin, and Deniz Dogru, and Nural Kiper, and Ayhan Gocmen
May 2007, American journal of respiratory and critical care medicine,
Nazan Cobanoglu, and Halil Atasoy, and Ugur Ozcelik, and Ebru Yalcin, and Deniz Dogru, and Nural Kiper, and Ayhan Gocmen
January 2013, Allergologia et immunopathologia,
Nazan Cobanoglu, and Halil Atasoy, and Ugur Ozcelik, and Ebru Yalcin, and Deniz Dogru, and Nural Kiper, and Ayhan Gocmen
July 2017, Indian pediatrics,
Nazan Cobanoglu, and Halil Atasoy, and Ugur Ozcelik, and Ebru Yalcin, and Deniz Dogru, and Nural Kiper, and Ayhan Gocmen
November 1999, Thorax,
Nazan Cobanoglu, and Halil Atasoy, and Ugur Ozcelik, and Ebru Yalcin, and Deniz Dogru, and Nural Kiper, and Ayhan Gocmen
April 2001, Archives of disease in childhood,
Nazan Cobanoglu, and Halil Atasoy, and Ugur Ozcelik, and Ebru Yalcin, and Deniz Dogru, and Nural Kiper, and Ayhan Gocmen
November 1999, Thorax,
Nazan Cobanoglu, and Halil Atasoy, and Ugur Ozcelik, and Ebru Yalcin, and Deniz Dogru, and Nural Kiper, and Ayhan Gocmen
November 2017, Indian pediatrics,
Copied contents to your clipboard!